pharma · Cervical Cancer · Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical
Sichuan Baili Pharmaceutical Co.,
Sichuan Baili Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Cervical Cancer, Non-small Cell Lung Cancer, Breast Cancer, Non Small Cell Lung Cancer. NovaPharmaNews li
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 4
- Drugs
- 0
- Patents
- 0
SI-B001
Phase 2 · small molecule · Non Small Cell Lung Cancer
SI-B001 for Non Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Sichuan Baili Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code SI-B001_201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sichuan Baili Pharmaceutical Co.,
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non Small Cell Lung Cancer
- Status
- active
- Trials
- 1